Vascular Disease and Surgery

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

Antithrombotic Therapy after Venous Stent Placement

Published:

16 October 2020

Citation:

Vascular & Endovascular Review 2020;3:e10.

Anticoagulation in Peripheral Artery Disease: Are We There Yet?

Published:

04 September 2020

Citation:

Vascular & Endovascular Review 2020;3:e09.

Metformin AAA Suppression Trial

Published:

08 July 2020

Citation:

Vascular & Endovascular Review 2020;3:e08.

DVT Lysis: Who, When, and How

Published:

17 June 2020

Citation:

Vascular & Endovascular Review 2020;3:e07.